Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

WHO sees high risk as polio breaks out in Central African Republic

Published 28/05/2019, 11:06
WHO sees high risk as polio breaks out in Central African Republic

GENEVA, May 28 (Reuters) - Two cases of polio have been
reported in the Central African Republic, the World Health
Organization said in a report on Tuesday, the latest setback for
global efforts to eradicate the crippling disease.
The cases, reported to WHO on May 24, were caused by
"vaccine-derived" polio rather than the wild type of the virus
that still circulates in Pakistan and Afghanistan.
"There is a high risk of transmission of the virus as both
cases were among internally displaced persons (in an area) with
an estimated population of eight thousand," the report said.
"The two cases had no previous history of vaccination for
polio. Vaccination coverage in the affected district is 50% with
insecurity being one of the main obstacles to access."
Latest figures from the Global Polio Eradication Initiative
show there have been 10 vaccine-derived polio cases this year:
eight in Nigeria, one in Somalia and one in Democratic Republic
of Congo. Pakistan and Afghanistan have reported 24 cases of the
wild type.
Polio is a virus that spreads in areas with poor sanitation.
It attacks the nervous system and can cause irreversible
paralysis within hours of infection. Children under five are the
most vulnerable, but polio can be prevented with vaccination.
Vaccine-derived cases tend to occur in places with low
vaccine coverage and poor sanitation as people who have been
vaccinated excrete the virus, putting those who have not been
vaccinated at risk of catching it.
The risk of vaccine-derived polio cases can be avoided by
switching from using live oral polio vaccines (OPV) - which are
highly effective, cheap and easy to deliver but contain live
virus - to "inactivated" vaccines (IPV), which are not effective
for fighting the wild type but contain no live virus.
The use of OPV is being scaled down in a phased manner as
countries eliminate circulating wild polio virus strains.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.